- Zymeworks (ZYME, Financial) will announce its Q2 2025 earnings on August 7, 2025, post-market close.
- The company will hold a conference call and webcast at 4:30 PM ET on the same day.
- Zymeworks will also participate in investor conferences in July and August 2025.
Zymeworks Inc. (ZYME), a clinical-stage biotechnology company, is set to release its second quarter 2025 financial results on August 7, 2025, after market close. To discuss these results and provide a corporate update, the company will host a conference call and webcast on the same day at 4:30 PM Eastern Time (ET). Investors can access the live webcast and its replay through Zymeworks' website.
In addition to the earnings announcement, Zymeworks' management will participate in two significant investor conferences this summer. The company will engage in one-on-one meetings and a fireside chat at the BTIG Virtual Biotechnology Conference on July 29, 2025. Additionally, from August 11-13, 2025, they will attend the Stifel Biotech Summer Summit in Newport, Rhode Island, offering further opportunities for investor engagement.
Zymeworks continues to advance its diverse pipeline of novel biotherapeutics aimed at treating difficult-to-treat diseases such as cancer, inflammation, and autoimmune conditions, further emphasizing its commitment to innovation in the biotech sector.
